Over the last decade oxylipins have become more recognized for their involvement in several diseases. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are known to inhibit cyclooxygenase (COX) enzymes, but how NSAIDs affect oxylipins, in addition to COX products, in animal tissues is not well understood. Investigation of oxylipins in livers from male and female mice treated with 100mg/kg/day of ibuprofen for 7 days showed that oxylipins and COX products that were altered by ibuprofen in male livers were 7 times more than in female livers. In male and female livers some prostaglandins were altered, while diols, hydroxy fatty acids and epoxides were only significantly altered in male livers. Some soluble epoxide hydrolase (sEH) products, such as 9,10-DiHODE were found to be decreased, while sEH substrates (such as 9(10)-EpODE) were found to be increased in male livers treated with ibuprofen, but not in female livers. The enzymatic activities of sEH and microsomal epoxide hydrolase (mEH) were elevated by ibuprofen in both males and females. Analyzing the influence of sex on the effect of ibuprofen on oxylipins and COX products showed that approximately 27% of oxylipins detected were influenced by sex. The results reveal that ibuprofen disturbs not only the COX pathway, but also the CYP450 and lipoxygenase pathways in male mice, suggesting that ibuprofen is likely to generate sex related differences in biologically active oxylipins. Increased sEH activity is likely to be one of the mechanisms by which ibuprofen alters the CYP450 pathway.